- Home
- TFX
as 01-21-2025 4:00pm EST
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
| Founded: | 1943 | Country: | United States |
| Employees: | N/A | City: | WAYNE |
| Market Cap: | 8.3B | IPO Year: | N/A |
| Target Price: | $252.50 | AVG Volume (30 days): | 496.2K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.03 | EPS Growth: | -41.10 |
| 52 Week Low/High: | $171.69 - $256.85 | Next Earning Date: | 02-20-2025 |
| Revenue: | $3,025,824,000 | Revenue Growth: | 2.27% |
| Revenue Growth (this year): | 4.56% | Revenue Growth (next year): | 4.76% |
Latest Teleflex Incorporated News
TFX Breaking Stock News: Dive into TFX Ticker-Specific Updates for Smart Investing
Argus Research
7 days ago
TFX: Lowering target price to $188.00
Zacks
9 days ago
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last?
MT Newswires
12 days ago
Teleflex Reports Central Venous Catheters Contract From Vizient
GlobeNewswire
13 days ago
Teleflex awarded Short Term Central Venous Catheters contract from Vizient
GlobeNewswire
15 days ago
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Zacks
a month ago
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Argus Research
a month ago
TFX: What does Argus have to say about TFX?
Zacks
a month ago
Here's Why Teleflex (TFX) is a Strong Value Stock
Compare TFX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TFX Teleflex Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.